GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ahn-Gook Pharmaceutical Co Ltd (XKRX:001540) » Definitions » YoY EBITDA Growth

Ahn-Gook Pharmaceutical Co (XKRX:001540) YoY EBITDA Growth : -36.39% (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Ahn-Gook Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ahn-Gook Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -36.39%.

Ahn-Gook Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2025 was ₩663.56.

Ahn-Gook Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Ahn-Gook Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ahn-Gook Pharmaceutical Co YoY EBITDA Growth Chart

Ahn-Gook Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.61 49.74 48.77 -23.89 226.57

Ahn-Gook Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 139.53 497.73 32.34 885.55 -36.39

Ahn-Gook Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ahn-Gook Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(2721.926-833.495)/ | 833.495 |
=226.57 %

Ahn-Gook Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(663.559-1043.232)/ | 1043.232 |
=-36.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ahn-Gook Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ahn-Gook Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ahn-Gook Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ahn-Gook Pharmaceutical Co Ltd (XKRX:001540) » Definitions » YoY EBITDA Growth
Comparable Companies
XKRX:067290 XKRX:061250 XKRX:012790 XKRX:183490 XKRX:142280 XKRX:229500 XKRX:004310 XKRX:000220 XKRX:002800 XKRX:131030 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
993-75, Daerim-Dong, Yeongdeungpo-Gu, Seoul, KOR, 150-072
Website
http://www.ahn-gook.com
Ahn-Gook Pharmaceutical Co Ltd manufactures and markets medicines. The company is famous for medicine for ophthalmology. The company also engages in various prescription medicines.

Ahn-Gook Pharmaceutical Co Headlines

No Headlines